3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urothelial Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Solid Malignancies
1
Advanced Rare Malignant Solid Neoplasm
1
Interventions
Paclitaxel
8
Radiotherapy
7
Cisplatin
6
pembrolizumab
4
Fluorouracil
4
Surgical Procedures, Operative
3
Radiation
3
Oxaliplatin
3
Levoleucovorin
3
Leucovorin
3
Esophagectomy
3
Drug Therapy
3
Carboplatin
3
lenvatinib
2
durvalumab
2
Taxes
2
TP protocol
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Neoadjuvant Therapy
2
Irinotecan
2
Capecitabine
2
trifluridine tipiracil drug combination
1
tislelizumab
1
palbociclib
1
osimertinib
1
obinutuzumab
1
nedaplatin
1
naptumomab estafenatox
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Squamous Cell Carcinoma
×
Tiragolumab
×
Clear all
NCT04543617
2026-04-17
SKYSCRAPER-07
Hoffmann-La Roche
Phase 3
Active not recruiting
760 enrolled